(GLOBE NEWSWIRE) -- Immunomedics, Inc., (Nasdaq:IMMU) today announced that, in a mid-stage clinical study, a multitude of patients with late stage... ...http://www.bizwireexpress.com/showstoryGNW.php?storyid=67464
Custom Search Genticel to Present Further Promising Pharmacology In-Vivo Results of Its Phase 2 Immunotherapeutic Vaccine... ...http://www.bizwireexpress.com/showstoryGNW.php?storyid=67453
- Bavituximab Alone and in Combination with Docetaxel Elicit a Tumor-Specific Immune Response in PD-L1 Negative Tumors Extracted from NSCLC... ...http://www.bizwireexpress.com/showstoryGNW.php?storyid=67366
By By | Reuters 7 minutes ago (Reuters) - A combination of two Bristol-Myers Squibb drugs that help the immune system fight melanoma led to... ...https://in.news.yahoo.com/bristol-myers-immunotherapy-combo-promising-melanoma-study-123334805--finance.html
/PRNewswire-USNewswire/ -- LUNGevity Foundation, the nation's leading lung cancer nonprofit, kicks off Lung Cancer Hope Month this May with the... ...http://www.itnewsonline.com/prnewswire/LUNGevitys-Lung-Cancer-Hope-Month-Celebrates-Progress-and-Promise-of-Lung-Cancer-Research/373978
CANCER HEALER CENTER is a cancer...